Description
ALINITY REAGENTS, CONTROLS AND CONSUMABLES
First action · last action
2024-05-01 · 2025-07-24
Transactions
4
First transaction's obligation
$762,982
Base + all options value (sum of deltas)
$1,008,601
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C24624A0028
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-05-01+$762,982= $762,982
- Mod P000012024-06-27+$0= $762,982
- Mod P000022025-03-04+$763,114= $1,526,097
- Mod P000042025-07-24-$517,496= $1,008,601
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-05-01 | +$762,982 | $762,982 | ALINITY REAGENTS, CONTROLS AND CONSUMABLES |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2024-06-27 | +$0 | $762,982 | ALINITY REAGENTS, CONTROLS AND CONSUMABLES |
| Mod P00002· EXERCISE AN OPTION | 2025-03-04 | +$763,114 | $1,526,097 | ALINITY REAGENTS, CONTROLS AND CONSUMABLES |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-07-24 | −$517,496 | $1,008,601 | ALINITY REAGENTS, CONTROLS AND CONSUMABLES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NK5QDVJBHMN7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24126N0799 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $658,750 | FY2026 |
| 36C26326P0588 | NETWORK CONTRACT OFFICE 23 (36C263) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $308,299 | FY2026 |
| 36C24126A0041 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24226N0439 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,481,077 | FY2026 |
| 36C24926N0423 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $471,122 | FY2026 |
| 36C24626N0476 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $421,178 | FY2026 |
Other recipients under 6550 from 246-NETWORK CONTRACTING OFFICE 6 (36C246) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24626N0749 | BIOMERIEUX INC | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $165,286 | FY2026 |
| 36C24626N0683 | ROCHE DIAGNOSTICS CORPORATION | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $287,950 | FY2026 |
| 36C24626N0663 | CEPHEID | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $160,463 | FY2026 |
| 36C24626N0534 | CEPHEID | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $472,015 | FY2026 |
| 36C24626N0533 | CEPHEID | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $198,013 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24624N0736_3600_36C24624A0028_3600 · retrieved 2026-09-26.